The tariff classification of Darolutamide (CAS No. 1297538-32-9) in bulk form and Nubeqa® Tablets in dosage form, from Finland
Reasoning
The tariff classification of Darolutamide (CAS No. 1297538-32-9) in bulk form and Nubeqa® Tablets in dosage form, from Finland
Cite this ruling
CBP Ruling N306530 (3004909215): The tariff classification of Darolutamide (CAS No. 1297538-32-9) in bulk form and Nubeqa® Tablets in dosage form, from Finland
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 300490
The tariff classification of Metoprolol Extended Release Tablets, imported in dosage form, from India
The tariff classification of Felodipine Tablets, imported in dosage form, from India
The tariff classification of Amantadine Hydrochloride capsules and Acamprosate Calcium delayed release capsules in dosage form, from Spain and India, respectively
The tariff classification of Olmesartan Medoxomil Tablets and Spironolactone Tablets in dosage form, from India and China, respectively
The tariff classification of Amantadine Hydrochloride capsules and Acamprosate Calcium delayed release capsules in dosage form, from Spain and India, respectively